Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential CoolMini and Kybella for Submental Fat
NCT03510598Phase 4Completed
- Sponsor
- Zeltiq Aesthetics
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Neobella in submental fat, sponsored by Zeltiq Aesthetics. Primary endpoints: Proportion of Subjects Who Have at Least a 1-grade Improvement on the Clinician Reported Submental Fat Rating Scale, Proportion of Subjects for Whom a 2-grade Improvement Was Recorded Using the CR-SMFRS and 1 more. Started Mar 2018; status: completed.
02
Drugs
Neobella
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT03510598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03510598.